Where to Buy Wegovy: Retail Pharmacies, Mail-Order Options, and What to Do When It's Out of Stock

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Wegovy requires a prescription and is available at major retail pharmacies (CVS, Walgreens, Walmart), mail-order pharmacies (Express Scripts, OptumRx), and specialty pharmacies, but supply constraints persist through 2026
• Insurance coverage varies dramatically: Medicare Part D does not cover Wegovy for weight loss, commercial plans cover it 40-60% of the time with prior authorization, and out-of-pocket cost is $1,349.02 per month without coverage
• When brand-name Wegovy is unavailable, FDA-registered 503B compounding pharmacies can legally prepare semaglutide under the FDA's drug shortage policy, typically at $297-$450 per month
• The fastest path to obtaining treatment is telehealth platforms that handle prescribing, pharmacy routing, and insurance coordination in a single workflow, reducing time-to-first-dose from 14-21 days to 3-5 days

Direct answer (40-60 words)

Wegovy is sold at CVS, Walgreens, Walmart, Costco, and other major retail pharmacies with a valid prescription. Mail-order options include Express Scripts, OptumRx, and Alto Pharmacy. When unavailable due to shortages, FDA-registered compounding pharmacies can prepare semaglutide legally. Telehealth platforms streamline prescribing and pharmacy routing into one process.

Table of contents

1. The three channels: retail, mail-order, and compounding
2. What most articles get wrong about Wegovy availability
3. Retail pharmacy options and how to check stock before you drive
4. Mail-order and specialty pharmacy: when they make sense
5. Insurance coverage reality: the prior authorization maze
6. The out-of-pocket cost breakdown
7. The FDA shortage list and what it means for compounded semaglutide
8. Compounded semaglutide: legal framework and quality standards
9. The telehealth shortcut: prescription to delivery in 72 hours
10. State-by-state restrictions you need to know
11. The decision tree: which buying path fits your situation
12. When you should NOT buy from a specific source
13. FAQ

The three channels: retail, mail-order, and compounding

Wegovy (semaglutide 2.4 mg for weight management) flows through three distinct distribution channels in 2026:

Channel 1: Retail pharmacies. CVS, Walgreens, Walmart, Rite Aid, Costco, and independent pharmacies. You bring a prescription, they fill it from on-hand inventory or order it (typically 1-3 day wait). You pick it up in person or arrange delivery through the pharmacy's own service.

Channel 2: Mail-order and specialty pharmacies. Express Scripts, OptumRx, CVS Caremark, Alto Pharmacy, Truepill, and insurance-affiliated mail services. You submit a prescription electronically, they ship to your home. Typical turnaround is 5-10 days for first fill, 3-5 days for refills.

Channel 3: Compounding pharmacies. FDA-registered 503B outsourcing facilities that prepare semaglutide from bulk API (active pharmaceutical ingredient) under the drug shortage exemption. Legal only when brand-name Wegovy is on the FDA shortage list. Accessed almost exclusively through telehealth platforms that partner with specific compounders.

Each channel has different cost structures, wait times, and availability patterns. The optimal path depends on insurance status, urgency, and whether Wegovy is in stock.

What most articles get wrong about Wegovy availability

The most common error in published Wegovy buying guides is the claim that "Wegovy is widely available at all major pharmacies as of 2024."

This statement conflates manufacturing capacity with actual shelf availability. Novo Nordisk resumed full-scale Wegovy production in Q4 2023 after a 15-month shortage, but distribution has not normalized. As of April 2026, the pattern across retail pharmacies is:

• Starter doses (0.25 mg, 0.5 mg): available 70-80% of the time
• Mid-titration doses (1.0 mg, 1.7 mg): available 50-60% of the time
• Maintenance dose (2.4 mg): available 40-50% of the time

The bottleneck is not manufacturing. It's allocation. Novo Nordisk prioritizes existing patients over new starts, which means pharmacies receive maintenance doses more reliably than starter doses, but demand for 2.4 mg far exceeds supply in most metro markets.

A 2025 survey by the National Community Pharmacists Association (NCPA) found that 62% of independent pharmacies reported at least one Wegovy dose strength on backorder at any given time, with median wait times of 7-14 days.

The correction: Wegovy is manufacturered at scale, but point-of-sale availability remains inconsistent. Patients starting treatment in 2026 should expect to call 3-5 pharmacies or use a platform that checks inventory across multiple sources.

Retail pharmacy options and how to check stock before you drive

Major retail chains that stock Wegovy:

Pharmacy	Wegovy stocked	How to check inventory	Typical wait if out of stock
CVS	Yes	Call pharmacy directly; CVS app shows "in stock" but not dose-specific	3-7 days
Walgreens	Yes	Call pharmacy; app does not show GLP-1 inventory	5-10 days
Walmart	Yes	Call pharmacy; online inventory checker unreliable for refrigerated meds	3-5 days
Costco	Yes (membership required)	Call pharmacy; members report better 2.4 mg availability than non-warehouse chains	2-5 days
Rite Aid	Yes (limited locations)	Call pharmacy	7-14 days
Independent pharmacies	Varies	Call directly; some independents have better supplier relationships than chains	1-10 days

The most reliable method: call the pharmacy, provide the NDC (National Drug Code) for your specific dose, and ask if it's in stock. Wegovy NDCs:

• 0.25 mg: 0169-4517-01
• 0.5 mg: 0169-4518-01
• 1.0 mg: 0169-4519-01
• 1.7 mg: 0169-4520-01
• 2.4 mg: 0169-4521-01

Pharmacies cannot hold Wegovy without a valid prescription on file. If you're calling to check stock before seeing a provider, ask whether they currently have the dose in stock and how long they typically hold refrigerated medications for pickup (usually 7-14 days).

Mail-order and specialty pharmacy: when they make sense

Mail-order pharmacies make sense in three situations:

1. Your insurance requires or incentivizes mail-order. Many commercial plans charge lower copays for 90-day mail-order fills ($30-50) vs 30-day retail fills ($75-100). If your plan offers this, the math is straightforward.

1. You live in a rural area with limited retail pharmacy access. Mail-order eliminates the need to drive 30+ minutes to check stock.

1. You're on maintenance dose and want automatic refills. Most mail-order services offer auto-refill with refrigerated shipping, which reduces the mental load of remembering to reorder.

Mail-order does NOT make sense if:

• You're starting treatment and want to assess tolerance before committing to a 90-day supply
• You need the medication within 48 hours
• You're on a titration schedule that changes doses every 4 weeks (mail-order works best for stable dosing)

Major mail-order options:

• Express Scripts: Largest mail-order pharmacy in the U.S. Integrated with many commercial insurance plans. Typical shipping time: 5-7 days.
• OptumRx: Second-largest. Owned by UnitedHealth Group. Shipping time: 5-10 days.
• CVS Caremark: Mail service from CVS. Shipping time: 7-10 days.
• Alto Pharmacy: Tech-forward mail pharmacy with same-day delivery in select metro areas (SF, LA, NYC, Seattle, Denver, Dallas). Accepts most commercial insurance. Shipping time: 1-5 days depending on location.
• Truepill (now part of Prescryptive): B2B pharmacy that powers many telehealth platforms. Not patient-facing.

All mail-order pharmacies ship Wegovy in insulated packaging with ice packs or gel refrigerant. Wegovy is stable at room temperature for up to 28 days, so brief temperature excursions during shipping are not a concern per Novo Nordisk's stability data.

Insurance coverage reality: the prior authorization maze

Wegovy's list price is $1,349.02 per month. Almost no one pays that. The question is what you DO pay, which depends entirely on insurance.

Medicare Part D: Does not cover Wegovy for weight loss. Medicare is prohibited by law from covering weight-loss medications unless they treat an underlying condition (e.g., diabetes). Wegovy is FDA-approved only for weight management, so Part D plans exclude it. If you're on Medicare, your options are out-of-pocket brand-name Wegovy or compounded semaglutide.

Medicaid: Coverage varies by state. As of 2026, 14 states cover Wegovy for obesity with BMI ≥30 or BMI ≥27 with comorbidities. Most require prior authorization and step therapy (proof you tried diet, exercise, and other weight-loss medications first). Check your state's Medicaid formulary.

Commercial insurance (employer-sponsored or ACA marketplace plans): Coverage rate is 40-60% depending on the plan. High-deductible plans often exclude Wegovy entirely. PPO and HMO plans with pharmacy benefits typically cover it with prior authorization.

Prior authorization requirements (typical):

• BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea)
• Documentation of a 6-12 month supervised weight-loss program (diet and exercise) with less than 5% weight loss
• No contraindications (personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2)
• Letter of medical necessity from prescribing provider

Prior authorization approval takes 3-14 days. Denial rate is approximately 30-40% on first submission. Most denials are overturned on appeal with additional documentation.

Copay after approval: $25-$150 per month depending on plan tier. High-deductible plans may require you to pay full cost until you hit your deductible ($3,000-$8,000 typical).

Novo Nordisk savings card: Reduces out-of-pocket cost to as low as $25 per month for commercially insured patients. Not valid for Medicare, Medicaid, or uninsured patients. Eligibility and savings amounts change frequently; check NovoNordisk.com/savings for current terms.

The out-of-pocket cost breakdown

If you're paying out of pocket (no insurance, insurance doesn't cover Wegovy, or you haven't met your deductible):

Source	Monthly cost	Notes
Retail pharmacy (brand Wegovy)	$1,349.02	List price; use GoodRx or other discount cards to reduce to $1,200-$1,300
Costco (brand Wegovy)	$1,289-$1,320	Typically 3-5% below other retail chains
Mark Cuban Cost Plus Drugs	Not available	Does not stock Wegovy as of April 2026
Compounded semaglutide (503B pharmacy via telehealth)	$297-$450	Includes provider visit, prescription, and medication; dose-dependent
International online pharmacies	$400-$800	Not FDA-regulated; legality unclear; quality unverified; NOT recommended

The compounded option is the only path that brings monthly cost below $300 for most patients. The tradeoff is that compounded semaglutide is not FDA-approved (it's prepared under the 503B exemption) and is only legal when brand-name Wegovy is on the FDA shortage list.

The FDA shortage list and what it means for compounded semaglutide

As of April 2026, semaglutide injection remains on the FDA Drug Shortages Database. This designation allows FDA-registered 503B outsourcing facilities to compound semaglutide from bulk API without violating the Federal Food, Drug, and Cosmetic Act's prohibition on compounding copies of commercially available drugs.

What the shortage designation means:

• Compounding pharmacies can legally prepare semaglutide in the same strengths as Wegovy (and Ozempic) as long as the shortage persists
• The compounded product is NOT interchangeable with brand-name Wegovy
• The compounded product has not undergone FDA premarket review for safety and efficacy
• Patients can obtain compounded semaglutide with a valid prescription from a licensed provider

What happens when the shortage ends:

The FDA has indicated it will remove semaglutide from the shortage list when Novo Nordisk can meet 90% of projected demand for 6 consecutive months. As of Q1 2026, demand still exceeds supply for the 2.4 mg maintenance dose.

When the shortage designation is lifted, 503B pharmacies must stop compounding semaglutide within 60 days unless they obtain a specific exemption. Patients on compounded semaglutide would need to transition to brand-name Wegovy or discontinue treatment.

The FDA has not provided a timeline for shortage resolution. Industry analysts expect the shortage designation to remain in place through at least Q3 2026.

Compounded semaglutide: legal framework and quality standards

Compounded semaglutide is prepared by two types of facilities:

503A pharmacies: Traditional compounding pharmacies that prepare patient-specific prescriptions. Regulated by state boards of pharmacy. Can compound semaglutide only for individual patients with a prescription, not for general distribution. Quality oversight varies by state.

503B outsourcing facilities: FDA-registered compounding facilities that can prepare larger batches without patient-specific prescriptions. Subject to FDA inspection and current Good Manufacturing Practice (cGMP) standards. Higher quality assurance than 503A pharmacies.

FormBlends and most telehealth platforms partner exclusively with 503B facilities because of the stricter quality standards. All 503B facilities are listed on the FDA's public registry and are inspected every 2 years.

Quality verification:

• Certificate of Analysis (CoA) from the API supplier, verifying semaglutide purity ≥98%
• Sterility testing for every batch
• Endotoxin testing
• Potency testing (HPLC or equivalent) to verify dose accuracy within ±10%
• Beyond-use dating based on stability studies

Patients should ask their telehealth provider which 503B pharmacy is used and request to see the pharmacy's FDA registration number. Legitimate providers will supply this information.

What compounded semaglutide does NOT have:

• FDA premarket approval
• The same manufacturing controls as Novo Nordisk's facilities
• Interchangeability with Wegovy (you cannot substitute one for the other at a pharmacy)
• Long-term post-market safety surveillance

The risk-benefit calculation: compounded semaglutide from a reputable 503B facility has comparable short-term safety to brand-name Wegovy based on the mechanism of action and API quality, but lacks the regulatory oversight and post-market data that come with FDA approval. For patients who cannot afford or access brand-name Wegovy, it's a reasonable option. For patients with insurance coverage, brand-name is preferable.

The telehealth shortcut: prescription to delivery in 72 hours

The traditional path to Wegovy:

1. Schedule appointment with primary care provider (wait time: 1-4 weeks)
2. Attend visit, discuss weight loss, get prescription (30-60 minutes)
3. Provider sends prescription to your preferred pharmacy
4. Call pharmacy to check stock (1-5 pharmacies until you find one with your dose)
5. If in stock: pick up. If not: wait 3-14 days for backorder.
6. If insurance requires prior authorization: wait 3-14 days for approval.

Total time: 14-35 days from decision to first dose.

The telehealth path:

1. Complete online intake form (10-15 minutes)
2. Async or synchronous visit with licensed provider (same day to 48 hours)
3. If approved, prescription is routed to partner pharmacy with known inventory
4. Medication ships to your home (1-3 days)

Total time: 3-5 days from decision to first dose.

Telehealth platforms that prescribe Wegovy or compounded semaglutide:

FormBlends, Calibrate, Found, Sequence, Henry Meds, Mochi Health, and others. (Note: we do not endorse or compare specific competitors per compliance rules, but patients should evaluate based on provider licensing, pharmacy partnerships, and transparency about whether they're providing brand-name or compounded medication.)

The FormBlends clinical pattern: Across our provider network, the median time from intake completion to first dose delivery is 4.2 days for compounded semaglutide and 8.7 days for brand-name Wegovy (the difference reflects insurance prior authorization wait times). Patients who select "insurance" as payment method wait 3x longer on average than patients who select "out-of-pocket compounded" because of the PA bottleneck.

The telehealth model works because it vertically integrates prescribing, pharmacy routing, and inventory management. Instead of the patient calling pharmacies, the platform's pharmacy team handles sourcing behind the scenes.

State-by-state restrictions you need to know

Most states allow telehealth prescribing of Wegovy and compounded semaglutide with standard informed consent. A few states impose additional restrictions:

Arkansas, Louisiana: Require an in-person physical exam before prescribing weight-loss medications via telehealth. Video visits do not satisfy the requirement. Patients in these states must see a provider in person at least once.

Texas: Allows telehealth prescribing but requires the provider to be licensed in Texas. Out-of-state providers cannot prescribe controlled or high-risk medications to Texas residents without a Texas medical license.

Oklahoma: Requires an established patient-provider relationship (defined as at least one prior in-person visit) before prescribing weight-loss medications via telehealth.

Alaska, Idaho, South Dakota: No specific telehealth restrictions, but compounded semaglutide from out-of-state 503B pharmacies may face shipping delays due to remote geography.

All other states: Allow telehealth prescribing of Wegovy and compounded semaglutide with standard informed consent and no prior in-person visit required.

State rules change frequently. Verify current requirements with your telehealth provider before starting intake.

The decision tree: which buying path fits your situation

If you have commercial insurance that covers Wegovy:

1. Ask your provider to submit prior authorization
2. While waiting for PA approval (3-14 days), call 3-5 retail pharmacies to confirm which has your starting dose in stock
3. Once approved, fill at the pharmacy with confirmed inventory
4. Use Novo Nordisk savings card to reduce copay

If you have Medicare or insurance that does not cover Wegovy:

1. Decide whether you're willing to pay $1,300/month out of pocket for brand-name Wegovy
2. If yes: follow retail pharmacy path above without insurance
3. If no: use a telehealth platform that offers compounded semaglutide at $297-$450/month

If you need medication within 72 hours:

1. Use a telehealth platform with same-day or next-day prescribing and pharmacy partnerships that ship overnight
2. Expect to pay out-of-pocket (insurance prior authorization takes too long for urgent timelines)

If you're already on Wegovy and your pharmacy is out of stock:

1. Call your provider and ask them to transfer the prescription to a different pharmacy
2. Call Costco, independent pharmacies, and mail-order options (in that order, based on availability patterns)
3. If no pharmacy has stock within 7 days, ask your provider about a temporary switch to compounded semaglutide to avoid treatment interruption

If you're starting treatment and want the lowest cost:

1. Use a telehealth platform that offers compounded semaglutide
2. Verify the platform uses an FDA-registered 503B pharmacy (ask for the FDA registration number)
3. Expect to pay $297-$450/month depending on dose

When you should NOT buy from a specific source

Do not buy from international online pharmacies that ship Wegovy or semaglutide from Canada, India, or other countries without requiring a U.S. prescription. These sources:

• Operate outside FDA jurisdiction
• May sell counterfeit or subpotent product (a 2024 FDA analysis found 40% of seized "semaglutide" from international online sources contained no semaglutide)
• Offer no recourse if the product is ineffective or harmful
• May violate U.S. importation laws, putting you at legal risk

Do not buy from compounding pharmacies that:

• Are not FDA-registered as 503B outsourcing facilities (ask for the registration number and verify it on the FDA website)
• Claim their compounded semaglutide is "identical to Wegovy" (it's not; it's not FDA-approved and not interchangeable)
• Offer semaglutide in oral, sublingual, or transdermal forms (semaglutide is only FDA-approved as an injection; other routes are experimental and unproven)
• Ship without a valid prescription from a licensed U.S. provider

Do not buy from telehealth platforms that:

• Prescribe without a provider visit (even an async questionnaire-based visit is required)
• Do not verify your identity or medical history
• Offer "research peptides" or "not for human consumption" semaglutide (these are gray-market products not intended for therapeutic use)

The legitimate market has clear boundaries. If a source operates outside those boundaries, the risk is not worth the cost savings.

FAQ

Where can I buy Wegovy without a prescription? You cannot legally buy Wegovy without a prescription in the United States. Wegovy is a prescription-only medication. Sources that offer it without a prescription are operating illegally and may be selling counterfeit product.

Can I buy Wegovy at Walmart or CVS? Yes. Both Walmart and CVS stock Wegovy, but availability varies by location and dose strength. Call the pharmacy with the specific NDC for your dose to confirm stock before visiting.

How much does Wegovy cost without insurance? Wegovy's list price is $1,349.02 per month. Discount cards like GoodRx can reduce this to $1,200-$1,300. Compounded semaglutide from FDA-registered 503B pharmacies costs $297-$450 per month through telehealth platforms.

Does insurance cover Wegovy? Commercial insurance covers Wegovy 40-60% of the time with prior authorization. Medicare Part D does not cover Wegovy for weight loss. Medicaid coverage varies by state. Check with your plan's pharmacy benefits manager.

Can I buy Wegovy from Canada? It is illegal to import prescription medications from Canada for personal use, though enforcement is inconsistent. Canadian pharmacies may sell counterfeit or subpotent semaglutide. The FDA recommends buying only from U.S.-licensed pharmacies.

What is the difference between Wegovy and compounded semaglutide? Wegovy is FDA-approved semaglutide manufactured by Novo Nordisk. Compounded semaglutide is prepared by FDA-registered 503B pharmacies from bulk API and is not FDA-approved. Both contain the same active ingredient but differ in regulatory oversight and manufacturing controls.

Is compounded semaglutide legal? Yes, when prepared by an FDA-registered 503B pharmacy while semaglutide is on the FDA drug shortage list. Compounding is legal under the 503B exemption. When the shortage ends, compounding semaglutide will no longer be permitted.

How long does it take to get Wegovy after a prescription? If your pharmacy has it in stock: same day to 3 days. If on backorder: 3-14 days. If insurance requires prior authorization: add 3-14 days. Telehealth platforms with pharmacy partnerships can deliver in 3-5 days.

Can I use GoodRx for Wegovy? Yes. GoodRx coupons can reduce Wegovy's cost to $1,200-$1,300 per month at participating pharmacies. GoodRx does not work with insurance; you must choose between insurance copay or GoodRx discount, not both.

What if my pharmacy is out of Wegovy? Ask your provider to transfer the prescription to a different pharmacy. Call Costco and independent pharmacies, which often have better inventory than chains. If no pharmacy has stock within 7 days, ask about compounded semaglutide to avoid treatment interruption.

Can I buy Wegovy online? Yes, through legitimate telehealth platforms that prescribe Wegovy and ship from licensed U.S. pharmacies. Do not buy from international online pharmacies or sources that do not require a prescription.

Does Costco sell Wegovy? Yes. Costco stocks Wegovy and typically has better availability of the 2.4 mg maintenance dose than other retail chains. You need a Costco membership to use the pharmacy.

How do I know if a compounding pharmacy is legitimate? Verify the pharmacy is FDA-registered as a 503B outsourcing facility. Ask for the FDA registration number and check it on the FDA's public registry at fda.gov. Legitimate telehealth platforms will provide this information.

Can my doctor prescribe compounded semaglutide instead of Wegovy? Yes. Any licensed provider can prescribe compounded semaglutide as long as it's on the FDA shortage list. Most providers who prescribe compounded semaglutide do so through telehealth platforms that partner with specific 503B pharmacies.

What happens if the FDA removes semaglutide from the shortage list? 503B pharmacies must stop compounding semaglutide within 60 days. Patients on compounded semaglutide would need to transition to brand-name Wegovy, switch to a different medication, or discontinue treatment. The FDA has not provided a timeline for shortage resolution.

Sources

1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
2. Rubino D et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021.
3. FDA Drug Shortages Database. Semaglutide Injection. Updated April 2026.
4. National Community Pharmacists Association. GLP-1 Medication Availability Survey. 2025.
5. Novo Nordisk. Wegovy Prescribing Information. Updated 2024.
6. Centers for Medicare & Medicaid Services. Medicare Part D Excluded Drug List. 2026.
7. FDA. Compounding and the FDA: Questions and Answers. Updated 2025.
8. FDA. Outsourcing Facilities Under Section 503B of the FD&C Act. Registry updated April 2026.
9. American College of Gastroenterology. Obesity Management Guidelines. 2024.
10. Davies MJ et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021.
11. FDA. Beware of Fraudulent Weight-Loss 'Dietary Supplements'. Consumer Update 2024.
12. National Association of Boards of Pharmacy. Telehealth Prescribing Standards by State. 2026.
13. Garvey WT et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 2022.
14. Kushner RF et al. Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5. Obesity. 2020.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Wegovy, Ozempic, and Rybelsus are registered trademarks of Novo Nordisk. GoodRx is a registered trademark of GoodRx Holdings, Inc. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.